Dissolution phenomenon of the piretanide amorphous form involving phase change

Chemical and Pharmaceutical Bulletin

Volumn 44, Issue 11, 1996, Pages 2111-2115

  Chikaraishi, Yuji ^a   Otsuka, Makoto ^b   Matsuda, Yoshihisa ^b  

^a SANOFI   (France)

^b KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

amorphous form; initial dissolution rate; piretanide; solubility; stationary disk method

Indexed keywords

PIRETANIDE;

ARTICLE; DRUG SOLUBILITY; DRUG STRUCTURE; PH; PHASE TRANSITION; TEMPERATURE DEPENDENCE; THERMODYNAMICS; X RAY DIFFRACTION;

EID: 0029963787     PISSN: 00092363     EISSN: None     Source Type: Journal    
DOI: 10.1248/cpb.44.2111     Document Type: Article

References (12)

1. Chikaraishi Y., Otsuka M., Matsuda Y., Chem. Pharm. Bull., 43, 1966-1969 (1995).
2. Ueda H., Nambu N., Nagai T., Chem. Pharm. Bull., 32, 244-250 (1984).
3. Shefter E., Higuchi T., J. Pharm. Sci., 52, 781-791 (1963).
4. Wurster D. E., Taylor P. W., Jr., J. Pharm. Sci., 54, 670-676 (1965).
5. Nogami H., Nagai T., Yotsuyanagi T., Chem. Pharm. Bull., 17, 499-509 (1969).
6. Kaneniwa N., Ichikawa J., Matsumoto T., Chem. Pharm. Bull., 36, 1063-1073 (1988).
7. Otsuka M, Teraoka R., Matsuda Y., Chem. Pharm. Bull., 39, 2667-2670 (1991).
8. Otsuka M., Teraoka R., Matsuda Y., Pharmaceutical Research, 9, 307-311 (1992).
9. Chikaraishi Y., Otsuka M., Matsuda Y., Chem. Pharm. Bull., 44, 1614-1617 (1996).
10. Clark W. M., Lubs H. A., J. Bact., 2, 1-34, 109-136, 191-236 (1917).
11. Miller G. L., Golder R. H., Arch. Biochem., 29, 420-423 (1950).
12. Yamaoka T., Tanigawara T., Nakagawa T., Uno T., J. Pharmacobio-Dyn., 4, 879-885 (1981).